319 results on '"Curnis, Flavio"'
Search Results
2. A novel aminopeptidase N/CD13 inhibitor selectively targets an endothelial form of CD13 after coupling to proteins
3. Quantification of Chromogranin A and Its Fragments in Biological Fluids
4. Early diagnosis of bladder cancer by photoacoustic imaging of tumor-targeted gold nanorods
5. Contrast enhanced photoacoustic detection of fibrillar collagen in the near infrared region-I.
6. Improving the antitumor activity of R-CHOP with NGR-hTNF in primary CNS lymphoma: final results of a phase 2 trial
7. Enhancement of doxorubicin anti-cancer activity by vascular targeting using IsoDGR/cytokine-coated nanogold
8. R-CHOP preceded by blood-brain barrier permeabilization with engineered tumor necrosis factor-α in primary CNS lymphoma
9. Targeting CD13 with Asn-Gly-Arg (NGR) Peptide-Drug Conjugates
10. Chromogranin A in Endothelial Homeostasis and Angiogenesis
11. Ceruloplasmin oxidized and deamidated by Parkinson's disease cerebrospinal fluid induces epithelial cells proliferation arrest and apoptosis
12. Abstract 2381: Gold nanorods functionalized with an alpha5beta1 ligand: a simple and robust nanosystem for early bladder cancer detection
13. Supplementary Figure S4 from T Cells Redirected to a Minor Histocompatibility Antigen Instruct Intratumoral TNFα Expression and Empower Adoptive Cell Therapy for Solid Tumors
14. Supplementary Figure Legends from Chromogranin A Is Preferentially Cleaved into Proangiogenic Peptides in the Bone Marrow of Multiple Myeloma Patients
15. Supplementary Table S1 from T Cells Redirected to a Minor Histocompatibility Antigen Instruct Intratumoral TNFα Expression and Empower Adoptive Cell Therapy for Solid Tumors
16. Data from Chromogranin A Is Preferentially Cleaved into Proangiogenic Peptides in the Bone Marrow of Multiple Myeloma Patients
17. Supplementary figure and legend from Spatiotemporal Regulation of Tumor Angiogenesis by Circulating Chromogranin A Cleavage and Neuropilin-1 Engagement
18. Supplementary Table and Figure Legends from T Cells Redirected to a Minor Histocompatibility Antigen Instruct Intratumoral TNFα Expression and Empower Adoptive Cell Therapy for Solid Tumors
19. Data from Spatiotemporal Regulation of Tumor Angiogenesis by Circulating Chromogranin A Cleavage and Neuropilin-1 Engagement
20. Supplementary Data from Targeting Tumor Vasculature with TNF Leads Effector T Cells to the Tumor and Enhances Therapeutic Efficacy of Immune Checkpoint Blockers in Combination with Adoptive Cell Therapy
21. Supplementary Figures S1-S5 from Chromogranin A Is Preferentially Cleaved into Proangiogenic Peptides in the Bone Marrow of Multiple Myeloma Patients
22. Supplementary Methods and References. from T Cells Redirected to a Minor Histocompatibility Antigen Instruct Intratumoral TNFα Expression and Empower Adoptive Cell Therapy for Solid Tumors
23. Supplementary Tables S1-S4 from Chromogranin A Is Preferentially Cleaved into Proangiogenic Peptides in the Bone Marrow of Multiple Myeloma Patients
24. Supplementary Methods from Chromogranin A Is Preferentially Cleaved into Proangiogenic Peptides in the Bone Marrow of Multiple Myeloma Patients
25. Supplementary Figure 1 from Isoaspartate-Glycine-Arginine: A New Tumor Vasculature–Targeting Motif
26. Supplementary Figure 1 Legend from Isoaspartate-Glycine-Arginine: A New Tumor Vasculature–Targeting Motif
27. A stapled chromogranin A-derived peptide homes in on tumors that express αvβ6 or αvβ8 integrins
28. Neuropilin-1 and Integrins as Receptors for Chromogranin A-Derived Peptides
29. Targeting the Blood–Brain Tumor Barrier with Tumor Necrosis Factor-α
30. DIPG-21. DIPG cells alter the permeability of the blood-brain barrier in the brainstem leading to treatment failure.
31. Chromogranin A in Endothelial Homeostasis and Angiogenesis
32. Novel phage display-derived neuroblastoma-targeting peptides potentiate the effect of drug nanocarriers in preclinical settings
33. NGR-tagged nano-gold: A new CD13-selective carrier for cytokine delivery to tumors
34. A Novel RGD-4C-Saporin Conjugate Inhibits Tumor Growth in Mouse Models of Bladder Cancer
35. A new chromogranin A–dependent angiogenic switch activated by thrombin
36. Oxidized/deamidated-ceruloplasmin dysregulates choroid plexus epithelial cells functionality and barrier properties via RGD-recognizing integrin binding
37. Peptide-Mediated Targeting of Cytokines to Tumor Vasculature: The NGR-hTNF Example
38. Combined targeting of perivascular and endothelial tumor cells enhances anti-tumor efficacy of liposomal chemotherapy in neuroblastoma
39. Nanogold Functionalized With Lipoamide-isoDGR: A Simple, Robust and Versatile Nanosystem for αvβ3-Integrin Targeting
40. Additional file 1 of Enhancement of doxorubicin anti-cancer activity by vascular targeting using IsoDGR/cytokine-coated nanogold
41. Chromogranin A binds to αvβ6-integrin and promotes wound healing in mice
42. The neovasculature homing motif NGR: more than meets the eye
43. Role of vasostatin-1 C-terminal region in fibroblast cell adhesion
44. Circulating Chromogranin A Is Cleaved Into Vasoregulatory Fragments in Patients With Pancreatic Ductal Adenocarcinoma
45. NGR-TNF Engineering with an N-Terminal Serine Reduces Degradation and Post-Translational Modifications and Improves Its Tumor-Targeting Activity
46. Immunogenic and structural properties of the Asn-Gly-Arg (NGR) tumor neovasculature-homing motif
47. Blood-Brain Barrier Permeabilization with Engineered Tumor Necrosis Factor-α Followed by R-CHOP Is an Active and Safe Salvage Therapy in Primary CNS Lymphoma
48. Boosting Interleukin‐12 Antitumor Activity and Synergism with Immunotherapy by Targeted Delivery with isoDGR‐Tagged Nanogold
49. Myocardial production of chromogranin A in human heart: a new regulatory peptide of cardiac function
50. Improving chemotherapeutic drug penetration in tumors by vascular targeting and barrier alteration
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.